vs
Side-by-side financial comparison of Employers Holdings, Inc. (EIG) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Employers Holdings, Inc. is the larger business by last-quarter revenue ($170.5M vs $164.7M, roughly 1.0× PTC THERAPEUTICS, INC.). On growth, Employers Holdings, Inc. posted the faster year-over-year revenue change (-21.3% vs -22.7%). Over the past eight quarters, Employers Holdings, Inc.'s revenue compounded faster (-11.4% CAGR vs -11.5%).
Employers Holdings, Inc. is a U.S.-headquartered insurance holding company that specializes in offering workers' compensation insurance and customized risk management services primarily for small and medium-sized enterprises across the United States. It mainly serves clients in low-to-medium hazard industries, helping them mitigate workplace safety risks and meet relevant regulatory requirements for employee protection.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
EIG vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $170.5M | $164.7M |
| Net Profit | — | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | — | -82.0% |
| Revenue YoY | -21.3% | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $170.5M | — | ||
| Q4 25 | $188.5M | $164.7M | ||
| Q3 25 | $239.3M | $211.0M | ||
| Q2 25 | $246.3M | $178.9M | ||
| Q1 25 | $202.6M | $1.2B | ||
| Q4 24 | $216.6M | $213.2M | ||
| Q3 24 | $224.0M | $196.8M | ||
| Q2 24 | $217.0M | $186.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $-8.3M | $15.9M | ||
| Q2 25 | $29.7M | $-64.8M | ||
| Q1 25 | $12.8M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $30.3M | $-106.7M | ||
| Q2 24 | $31.7M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -43.3% | ||
| Q3 25 | -4.7% | 1.4% | ||
| Q2 25 | 15.0% | -19.5% | ||
| Q1 25 | 7.8% | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 16.4% | -27.7% | ||
| Q2 24 | 18.4% | -21.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | -82.0% | ||
| Q3 25 | -3.5% | 7.5% | ||
| Q2 25 | 12.1% | -36.3% | ||
| Q1 25 | 6.3% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 13.5% | -54.2% | ||
| Q2 24 | 14.6% | -53.1% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.93 | $-1.63 | ||
| Q3 25 | $-0.36 | $0.20 | ||
| Q2 25 | $1.23 | $-0.83 | ||
| Q1 25 | $0.52 | $10.04 | ||
| Q4 24 | $1.14 | $-0.85 | ||
| Q3 24 | $1.21 | $-1.39 | ||
| Q2 24 | $1.25 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.9M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $955.7M | $-205.3M |
| Total Assets | $3.4B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $169.9M | — | ||
| Q4 25 | $169.9M | $1.9B | ||
| Q3 25 | $172.4M | $1.7B | ||
| Q2 25 | $78.1M | $2.0B | ||
| Q1 25 | $100.4M | $2.0B | ||
| Q4 24 | $68.4M | $1.1B | ||
| Q3 24 | $173.9M | $1.0B | ||
| Q2 24 | $126.4M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | $19.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $955.7M | — | ||
| Q4 25 | $955.7M | $-205.3M | ||
| Q3 25 | $1.0B | $-155.8M | ||
| Q2 25 | $1.1B | $-206.5M | ||
| Q1 25 | $1.1B | $-185.8M | ||
| Q4 24 | $1.1B | $-1.1B | ||
| Q3 24 | $1.1B | $-1.1B | ||
| Q2 24 | $1.0B | $-980.2M |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $2.9B | ||
| Q3 25 | $3.5B | $2.6B | ||
| Q2 25 | $3.5B | $2.6B | ||
| Q1 25 | $3.6B | $2.7B | ||
| Q4 24 | $3.5B | $1.7B | ||
| Q3 24 | $3.6B | $1.8B | ||
| Q2 24 | $3.5B | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | 0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | $-34.3M | ||
| Q3 25 | $29.4M | $-66.3M | ||
| Q2 25 | $0 | $-58.3M | ||
| Q1 25 | $14.6M | $870.1M | ||
| Q4 24 | $76.4M | $-30.0M | ||
| Q3 24 | $51.0M | $-77.0M | ||
| Q2 24 | $11.7M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | $76.3M | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | 23.7% | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | 35.2% | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 1.14× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 0.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
